NCT05976620View on ClinicalTrials.gov

Clinical Study of 18F-FAPI-RGD in Breast Tumors

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 20, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

February 20, 2024

Conditions
Breast Tumors
Trial Locations (1)

610072

Departments of Nuclear Medicine, Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors
lead

Sichuan Provincial People's Hospital

OTHER

NCT05976620 - Clinical Study of 18F-FAPI-RGD in Breast Tumors | Biotech Hunter | Biotech Hunter